We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PEI
1776
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $308K | ﹤0.01% |
37,103
-23,510
| -39% | -$369K |
|
|
AKRO
1777
DELISTED
Akero Therapeutics
AKRO
| $307K | ﹤0.01% |
9,985
-5,103
| -34% | -$178K |
|
1778
e.l.f. Beauty
ELF
$4.56B
| $307K | ﹤0.01% |
16,685
-65,187
| -80% | -$1.23M |
|
|
SRDX
1779
DELISTED
Surmodics
SRDX
| $307K | ﹤0.01% |
7,889
-6,501
| -45% | -$286K |
|
1780
Unisys
UIS
$227M
| $306K | ﹤0.01% |
28,703
-64,825
| -69% | -$744K |
|
|
DM
1781
DELISTED
Desktop Metal, Inc.
DM
| $306K | ﹤0.01% |
+2,830
| New | +$306K |
|
1782
CALL
Abbott
ABT
$180B
| $305K | ﹤0.01% |
+2,800
| New | +$284K |
|
|
ALLK
1783
DELISTED
Allakos
ALLK
| $305K | ﹤0.01% |
+3,739
| New | +$304K |
|
1784
Columbia Banking Systems
COLB
$8.81B
| $305K | ﹤0.01% |
12,778
-31,262
| -71% | -$863K |
|
1785
Cemex
CX
$17.4B
| $305K | ﹤0.01% |
80,194
+34,301
| +75% | +$112K |
|
|
1786
CALL
Pfizer
PFE
$140B
| $305K | ﹤0.01% |
8,748
| – | – |
|
|
1787
PUT
Pfizer
PFE
$140B
| $305K | ﹤0.01% |
8,748
| – | – |
|
|
WBT
1788
DELISTED
Welbilt, Inc.
WBT
| $305K | ﹤0.01% |
49,560
+23,242
| +88% | +$157K |
|
|
CNST
1789
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $305K | ﹤0.01% |
15,064
-3,696
| -20% | -$90.2K |
|
|
DESP
1790
DELISTED
Despegar.com
DESP
| $303K | ﹤0.01% |
+47,581
| New | +$379K |
|
|
JAMF
1791
DELISTED
Jamf
JAMF
| $303K | ﹤0.01% |
+8,061
| New | +$303K |
|
1792
National CineMedia
NCMI
$354M
| $303K | ﹤0.01% |
11,171
+9,577
| +601% | +$301K |
|
1793
Nkarta
NKTX
$162M
| $303K | ﹤0.01% |
+10,085
| New | +$297K |
|
1794
AnaptysBio
ANAB
$1.6B
| $302K | ﹤0.01% |
+20,473
| New | +$369K |
|
1795
Curis
CRIS
$9.53M
| $302K | ﹤0.01% |
645
+534
| +481% | +$252K |
|
|
ISBC
1796
DELISTED
Investors Bancorp, Inc.
ISBC
| $302K | ﹤0.01% |
+41,575
| New | +$331K |
|
|
RDS.B
1797
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $302K | ﹤0.01% |
12,477
-5,267
| -30% | -$151K |
|
|
ATSG
1798
DELISTED
Air Transport Services Group
ATSG
| $301K | ﹤0.01% |
12,025
-4,057
| -25% | -$101K |
|
|
AEGN
1799
DELISTED
Aegion Corp
AEGN
| $301K | ﹤0.01% |
+21,272
| New | +$335K |
|
1800
Cue Biopharma
CUE
$135M
| $300K | ﹤0.01% |
+665
| New | +$383K |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.